Renasant Bio Funding: $55M Raised, Seed (2025)

Renasant Bio is a Biotech company based in Berkeley, CA. It has raised $55M in total funding. Latest round: Seed.

Renasant Bio funding overview

Renasant Bio is a Biotech company based in Berkeley, CA. Renasant Bio has raised $55M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in January 2025. The round record for Renasant Bio runs through 2025; nothing later has been disclosed. Investors on record include 5AM Ventures, Atlas Venture, OrbiMed, Qiming Venture Partners. 4 distinct backers are named across the disclosed rounds.

Renasant Bio at a glance

Total raised
$55M
Latest round
Seed
Latest round date
January 2025
Industry
Biotech
Headquarters
Berkeley, CA
Notable investors
5AM Ventures, Atlas Venture, OrbiMed, Qiming Venture Partners

Frequently asked about Renasant Bio funding

How much has Renasant Bio raised?
Renasant Bio has raised $55M in total disclosed funding across the rounds on record.
Who has invested in Renasant Bio?
5AM Ventures, Atlas Venture, OrbiMed, Qiming Venture Partners are named among the investors backing Renasant Bio.
What was the latest Renasant Bio funding round?
The most recent disclosed round is a Seed, announced in January 2025.
Where is Renasant Bio based?
Renasant Bio is based in Berkeley, CA.
What sector does Renasant Bio operate in?
Renasant Bio is tracked under Biotech from Berkeley, CA, with $55M in disclosed funding.
When did Renasant Bio last raise?
The last disclosed Renasant Bio round closed in January 2025 at Seed.

Every Renasant Bio figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Berkeley at a similar stage.

Renasant Bio funding history

2 disclosed rounds on record, including 1 reported through SEC Form D filings.

  1. Filed July 2025 — Private financing. $30M sold of a $30M offering. 4 investors reported. SEC Form D filing
  2. January 2025 — Seed. $54.5M.

SEC Form D filings report the amount sold against a stated offering size, which can differ from press-reported round totals, and they do not name the round — those entries appear as Private financing.

Renasant Bio founders (1)

Companies related to Renasant Bio (40)

Browse related funding lists (6)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades